Tabula Rasa HealthCare, Inc. Common Stock
TRHC
TRHC was delisted on the 2nd of November, 2023.
80 hedge funds and large institutions have $79.3M invested in Tabula Rasa HealthCare, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 35 reducing their positions, and 27 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
89% more capital invested
Capital invested by funds: $41.9M → $79.3M (+$37.4M)
17% less funds holding
Funds holding: 96 → 80 (-16)
51% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 35
52% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 27
76% less call options, than puts
Call options by funds: $106K | Put options by funds: $447K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Indaba Capital Management
San Francisco,
California
|
+$5.8M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.94M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.61M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$1.49M |
| 5 |
Two Sigma Investments
New York
|
+$868K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$2.85M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.19M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$653K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$596K |
| 5 |
E
Ergoteles
New York
|
-$483K |
TRHC Hedge Fund Activity: Q3 2022 in Review
80 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Tabula Rasa HealthCare, Inc. Common Stock (TRHC) for Q3 2022, worth a combined $79.3M — up 89% from $41.9M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of TRHC and 13 opened new positions — a net loss of 14 holders — while 35 trimmed existing stakes and 17 added.
The largest buyer was Indaba Capital Management, adding an estimated $5.8M. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $2.85M sold.
- 80 institutional investors held Tabula Rasa HealthCare, Inc. Common Stock (TRHC) as of Q3 2022, down from 96 in Q2 2022.
- Funds reported $79.3M of Tabula Rasa HealthCare, Inc. Common Stock stock for Q3 2022, up 89% quarter-over-quarter.
- 13 funds opened new Tabula Rasa HealthCare, Inc. Common Stock positions in Q3 2022 and 27 closed out, a net change of -14 holders.
- The largest Tabula Rasa HealthCare, Inc. Common Stock buyer in Q3 2022 was Indaba Capital Management, an estimated $5.8M added.
- The largest Tabula Rasa HealthCare, Inc. Common Stock seller in Q3 2022 was D.E. Shaw & Co, an estimated $2.85M sold.
Based on aggregated 13F filings for Q3 2022.